Makaleler
85
Tümü (85)
SCI-E, SSCI, AHCI (57)
SCI-E, SSCI, AHCI, ESCI (61)
ESCI (4)
Scopus (75)
TRDizin (17)
Diğer Yayınlar (7)
14. Evaluation of Biodegradable Microparticles for Mucosal Vaccination Against Diphtheria Toxoid: Nasal Efficacy Studies in Guinea Pigs
Turkish Journal of Pharmaceutical Sciences
, cilt.20, sa.5, ss.294-301, 2023 (ESCI, Scopus, TRDizin)
21. Aşı Üretim Süreçlerinde Kalite Denetimi
SD
, sa.61, ss.52-55, 2022 (Hakemli Dergi)
25. Synthesis, biocompatibility and gene encapsulation of poly(2-Ethyl 2-Oxazoline)-dioleoyl phosphatidylethanolamine (PEtOx-DOPE) and post-modifications with peptides and fluorescent dye coumarin
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
, cilt.70, sa.14, ss.981-993, 2021 (SCI-Expanded, Scopus)
46. Preparation and Evaluation of TSP-1 Loaded Pegylated cationic Liposomes for Inhibiting Angiogenesis
International Journal of Biotechnology and Bioengineering
, cilt.3, sa.10, ss.317-321, 2017 (Hakemli Dergi)
50. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
, cilt.42, sa.11, ss.1865-1876, 2016 (SCI-Expanded, Scopus)
51. Gen taşınması için olası bir yaklaşım Poli 2 oksazolin tabanlı vektörler
Hacettepe University Journal of Faculty of Pharmacy,.
, cilt.2, sa.34, ss.113-132, 2015 (Hakemli Dergi)
54. Preparation and Characterization of Protein loaded Lipid polymer Hybrid Nanoparticles with Polycaprolactone as Polymeric Core Material
Biomolecular Research & Therapeutics
, cilt.3, sa.3, ss.1-4, 2014 (Hakemli Dergi)
60. Thermosensitive and pH induced in situ ophthalmic gelling system for ciprofloxacin hydrochloride: Hydroxypropyl-β-cyclodextrin complex
Acta Poloniae Pharmaceutica - Drug Research
, cilt.69, sa.6, ss.1137-1147, 2012 (SCI-Expanded, Scopus)
61. Effect of hydroxypropyl-β-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery
Acta Poloniae Pharmaceutica - Drug Research
, cilt.69, sa.4, ss.719-724, 2012 (SCI-Expanded, Scopus)
62. Formulation and in vitro characterization of PEGylated chitosan and polyethylene imine polymers with thrombospondin-I gene bearing pDNA
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
, cilt.100B, sa.4, ss.984-992, 2012 (SCI-Expanded, Scopus)
63. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
, cilt.37, sa.11, ss.1376-1386, 2011 (SCI-Expanded, Scopus)
66. PH INDUCED IN SITU OPHTHALMIC GELLING SYSTEM FOR CIPROFLOXACIN/HP-B-CD COMPLEX
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
, cilt.38, sa.1, ss.111-112, 2009 (SCI-Expanded)
67. Nanoteknoloji ve Nanobiyoteknoloji
TÜFTAD
, cilt.13, sa.2, ss.3-10, 2006 (Hakemsiz Dergi)
75. Ascorbic acid and uric acid levels in lung cancer patients
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
, cilt.24, sa.1, ss.43-47, 1999 (SCI-Expanded, Scopus)
80. Enemalar ve Enema Formülasyonlarında Yeni Gelişmeler
Ankara Üniversitesi Eczacılık Fakültesi Dergisi
, cilt.26, sa.1, ss.36-51, 1997 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
114
2. Production and Characterization of Lysozyme Loaded PLGA Nanoparticles by Microfluidic System
21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri)
5. PREFORMULATION OF NANOVACCINE LOADED DISSOLVING MICRONEEDLE FORMULATIONS
14th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 25 - 28 Haziran 2024, (Özet Bildiri)
6. INVESTIGATING THE IMPACT OF CROSS-LINKER TYPE ON PARTICLE SIZE AND ZETA POTENTIAL OF ALBUMIN NANOPARTICLES
14th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 25 - 28 Haziran 2024, (Özet Bildiri)
8. Ankara Üniversitesi Eczacılık fakültesi Öğrencileri ile 2023 Yılı Değerlendirmesinin Sonuçları
ECZAKDER 4.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 29 Şubat - 01 Mart 2024, ss.60, (Özet Bildiri)
9. Eczacılıkta Toplumsal Katkı Uygulamaları Dersi
ECZAKDER 4.Ulusal Eczacılık Eğitimi ve Akraditasyon Kongresi, Ankara, Türkiye, 29 Şubat - 01 Mart 2024, ss.61, (Özet Bildiri)
11. Aşı Üretim Süreçlerinde Kalite Denetimi” 4.Uluslararası Aşı Bilimi Kongresi, Covid-19 Aşı Teknolojileri, 3-5 Kasım 2022, Ankara
4.Uluslararası Aşı Bilimi Kongresi, Covid-19 Aşı Teknolojileri, Ankara, Türkiye, 03 Kasım 2022, (Tam Metin Bildiri)
12. Ankara Üniversitesi Eczacılık Fakültesi Öğrencilerinin ve Mezunlarının İhtiyaçlarının Analizi
ECZAKDER III. Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Türkiye, 17 - 19 Kasım 2021, (Özet Bildiri)
14. PREPARATION AND IN VITRO EVALUATION OF APO-E MODIFIED SOLID LIPID NANOPARTICLES FOR DELIVERY OF HUMANIN PEPTIDE
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Tam Metin Bildiri)
15. Polyelectrolyte Complex Nanoparticles-Filled Enteric-coated Capsules for Oral Insulin Delivery
13th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 22 - 25 Haziran 2021, ss.29-30, (Özet Bildiri)
16. “Covid-19 Aşıları, Formülasyon ve Stabilite Özellikleri”
TÜFTAD Online Toplantı Covid-19 Aşıları: Formülasyon, Kalite, Etkinlik, Güvenlilik ve Yerli Üretimi, Ankara, Türkiye, 06 Mart 2021, (Tam Metin Bildiri)
17. “Aşı Stabilite Çalışmaları”,Türk Konseyi Sağlık Bilim Kurulu/Aşı Çalıştayı- Davetli Konuşmacı , 25 Ağustos 2020, Urla-İzmir
Türk Konseyi Sağlık Bilim Kurulu/Aşı Çalıştayı- Davetli Konuşmacı , 25 Ağustos 2020, Urla-İzmir, İzmir, Türkiye, 25 Ağustos 2020, (Tam Metin Bildiri)
19. Development and in vitro/in vivo evaluation of a gelling system comprissing bisphosphonate loaded plga nanoparticles for guided bone regeneration
8th BBBB ınternational Conference on Pharmaceutical Scieneces, İzmir, Türkiye, 14 - 16 Ekim 2019, (Özet Bildiri)
20. Polymeric Drug Carriers for Targeted Therapy of Breast Cancer
EACR Nanotechnology in Cancer, 12 - 14 Eylül 2019, (Özet Bildiri)
21. Design of Partially Hydrolysed Poly(2-ethyl-2-oxazoline)-co-Poly(ethyleneimine)-b-Poly(ε-caprolactone) (PEtOx-co-PEI-b-PCL) Polymeric Carrier Systems
First International Balkan Chemistry Congress (IBCC), Sofija, Bulgaristan, 17 - 20 Eylül 2018, (Özet Bildiri)
22. EVALUATION OF STEALTH PROPERTIES OF PEtOx BASED MICELLE/GENE COMPLEXES BY STABILITY STUDIES
IPTS 2018, 17 - 19 Eylül 2018, (Özet Bildiri)
24. APOPTOTIC GENE THERAPY BY NOVEL DEVELOPED PARTIALLY HYDROLYSED PEtOx BASED MICELLAR NANOCARRIERS ON MCF-7 BREAST CANCER CELLS
IPTS2018, 17 - 19 Eylül 2018, (Özet Bildiri)
26. Doxorubicin and BIKDD Delivery to Au565 Breast Cancer Cell Line by Targeted Polymeric Nanocarriers
28th International Conference on Cancer Research and Anticancer Therapies, Illinois, Amerika Birleşik Devletleri, 17 - 18 Eylül 2018, (Özet Bildiri)
28. Factorial Design and Development of PLGA Microsparticles for Protein Delivery System
12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Özet Bildiri)
29. Nanobiyoteknoloji ve Hedeflenmiş Nanotaşıyıcı sistemler”, TÜSEB- Biyoteknolojik İlaçlarda Gelecek ve Türkiye Sempozyumu, 19-20 Nisan 2018, İstanbul.
TÜSEB- Biyoteknolojik İlaçlarda Gelecek ve Türkiye Sempozyumu, 19-20 Nisan 2018, İstanbul., İstanbul, Türkiye, 19 Nisan 2018, (Tam Metin Bildiri)
30. Synthesis of Anthocyanin-Rich Red cabbage Nanoflowers and Their Antimicrobial and Cytotoxic Properties
2nd International Conference on Natural Products for Cancer Prevention and Therapy, 8 - 11 Kasım 2017, (Özet Bildiri)
31. Targeting of Prostate Cancer with Polymeric Nanocarriers Labelled with PSMA-Binding Peptide
II International Conference on Cancer Research and Targeted Therapy, 26 - 28 Ekim 2017, (Özet Bildiri)
32. Nanocarrier-mediated co-delivery of pemetrexed and miR-21 antisense oligonucleotide for glioblastoma treatment
GPSS 2017, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)
33. IN-VITRO CHARACTERISATION OF PEPTIDE-563 CONJUGATED LIPOSOMES
GPSS 2017, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)
34. Characterisation and Evaluation of Targeted Liposomes. I- In vitro studies
BBBB International Conference on Pharmaceutical Sciences, 5 - 07 Ekim 2017, (Özet Bildiri)
35. BikDD and Doxorubicin Delivery to AU565 Breast Cancer Cell line by Targeted Lipid Based Nanovesicles
2nd International conference on Cancer Research and Targeted Therapy, MİAMİ, Amerika Birleşik Devletleri, 26 - 28 Ekim 2017, (Özet Bildiri)
36. Development and in vitro / in vivo evaluation of bisphosphonate loaded membranes for guided bone regeneration
12th International symposium on pharmaceutical sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)
37. Development of HPLC Method for Thymoquinone Quantification and Pre-Eliminary Investigation on Nanoparticle Production
22. Uluslararası Biyomedikal Bilim ve Teknoloji Sempozyumu, 12 - 14 Mayıs 2017, (Özet Bildiri)
38. Preparation and Evaluation of Cationic Liposomes for Cancer Treatment
22nd International Symposium on Biomedical Science and Technology, 12 - 14 Mayıs 2017, (Tam Metin Bildiri)
39. Characterization of inhalable nanocomposite microparticles loaded ciprofloxacin hydrochloride
22nd International Biomedical ScienceTechnology Symposium, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)
40. Comparison Studies on Peptide-18 ConjugatedLiposomes
22nd International Symposium on Biomedical Science and Technology, 12 - 14 Mayıs 2017, (Özet Bildiri)
41. Co-delivery of Pemetrexed and miR-21 Antisense Oligonucleotide by Cationic Solid Lipid Nanoparticles and Effects on Glioblastoma Cells
BIOMED 2017, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)
43. Characterization and Efficacy of Inhalable Nanocomposite Microparticles Loaded Ciprofloxacin Hydrochloride
22nd International Biomedical Science Technology Symposium BIOMED2017, 12 - 14 Mayıs 2017, (Özet Bildiri)
44. Evaluation of Morphological and Physical Characteristics of Poly(2-Ethyl-2-Oxazoline)-co-Poly(Ethylenimine)-Block-Poly(Ɛ-Caprolactone) (PEtOx-co-PEI-b-PCL) Polymeric Micelle as a Gene Delivery Agent
American Association of Pharmaceutical Scientists (AAPS)-National Biotechnology Conference, Alabama, Amerika Birleşik Devletleri, 1 - 03 Mayıs 2017, (Özet Bildiri)
46. Evaluation and Development of Dry Powder Inhaler Formulations That Comprising Nanoparticular Drug Delivery Systems for Administration by Pulmonary Route 4th Congress on Innovation in Drug Delivery Site Specific Drug Delivery 25 28 Eylül Antibes Fransa p 63 Poster No 48 2016
Poster Bildiri, Antalya, Türkiye, 25 - 28 Eylül 2016, (Özet Bildiri)
47. Evaluation and Development of Dry Powder Inhaler Formulations That Comprising Nanoparticular Drug Delivery Systems for Administration by Pulmonary Route
4th Congress on Innovation in Drug Delivery Site-Specific Drug Delivery, 25 - 28 Eylül 2016, (Özet Bildiri)
48. Preparation and Evaulation of Zoledronic Acid Loaded PLGA Nanoparticles 11th Central European Symposium on Pharmaceutical Technology 22 24 Eylül Belgrad Sırbistan Poster No 13 2016
poster tebliğ, Belgrade, Sırbistan, 22 - 24 Eylül 2016, (Özet Bildiri)
50. Preparation and evaluation of zolendronic acid loaded PLGA nanoparticles
arhiv za farmacıju, 22 - 24 Eylül 2016, (Tam Metin Bildiri)
51. Effect of External Aqueous Phase on the Ciprofloxacin HCl Loaded Poly Caprolactone Nanoparticles for Administration by Pulmonary Route
11th Central European Symposium on Pharmaceutical Technology, 22 - 24 Eylül 2016, (Tam Metin Bildiri)
53. Preparation and Evaulation of Zoledronic Acid Loaded PLGA Nanoparticles
11th Central European Symposium on Pharmaceutical Technology, 22 - 24 Eylül 2016, (Tam Metin Bildiri)
57. Farmasötik Biyoteknolojinin Bugünü ve Geleceği
PharmAnkara Ulusal Eczacılık Öğrenci Kongresi, Türkiye, 28 Nisan 2016
58. Aşı Bileşenleri ve Soğuk Zincir, Türkiye Halk Sağlığı Kurumu Aşı Çalıştayı
Türkiye Halk Sağlığı Kurumu Aşı Çalıştayı, Afyon, Türkiye, 7 - 09 Mart 2016, (Tam Metin Bildiri)
59. Farklı Taşıyıcı Sistemler Kullanarak Antijen İçeren Adjuvan Formülasyonlarının Geliştirilmesi
TÜSEB Sağlık Enstitüleri Başkanlığı,1.Aşı çalıştayı, Türkiye, 04 Şubat 2016
62. Evaluation of nanoparticle production process via central composite design for efficient zoledronic acid delivery
AAPS Annual Meeting and Exposition, 25 - 29 Ekim 2015, (Tam Metin Bildiri)
63. Optimization of Alendronat Sodium Loaded Nanoparticle Formulation for Higher Efficiency
AAPS Annual Meeting and Exposition, California, Amerika Birleşik Devletleri, 25 - 29 Ekim 2015, (Özet Bildiri)
64. Optimization of alendronate sodium loaded nanoparticle formulation for higher efficiency
AAPS Annual Meeting and Exposition, South Dakota, Amerika Birleşik Devletleri, 25 - 29 Ekim 2015, (Özet Bildiri)
65. Evaluation of Nanoparticle Production Process via central composite design for efficient zolendronik acid delivery
AAPS Annual Meeting and Exposition, California, Amerika Birleşik Devletleri, 25 - 29 Ekim 2015, (Özet Bildiri)
66. Evaluation and development of ciprofloxacin loaded nanoparticles for administration by pulmonary route
11th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 9 - 12 Haziran 2015, (Özet Bildiri)
67. Polymeric Nanoparticles for Intra Articular Application of Diclofenac Sodium
11th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 9 - 12 Haziran 2015
68. “Biyobenzer Ürünlerde Kalite” Biyoteknolojik Ürünler ve Biyobenzerler Kursu/Sempozyumu, İlaç Bilincini Geliştirme ve Akılcı İlaç Derneği, 21-23 Kasım 2014,Antalya.
İlaç Bilincini Geliştirme ve Akılcı İlaç Derneği, 21-23 Kasım 2014,Antalya., Ankara, Türkiye, 21 Kasım 2014, (Tam Metin Bildiri)
69. Preparation and characterization of microrna 21 antisense oligonucleotide and anticancer drug loaded lipid polymer hybrid nanoparticles and antitumor effects on glioblastoma cells
AAPS Annual Meeting and Exposition, Ankara, Türkiye, 2 - 06 Kasım 2014, (Özet Bildiri)
73. Preparation and evaulation of levofloxacin loaded PLGA microparticles for pulmonary delivery Effect of surfactant type and concentration on properties of microparticle
17th Internatıonal Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014
74. The effect of high pressure homogenization process on the particle size of solid lipid nanoparticles
16th International Pharmaceutical Technology Symposium, Antalya, Türkiye, 10 - 12 Eylül 2012, (Özet Bildiri)
75. Studies on the Mucosal Delivery of Microparticulate Antigen Delivery Systems II In-vitro Characterization
10th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2012, ss.327, (Özet Bildiri)
76. Preparation and evaluation of the model protein loaded thermosensitive in situ gelling systems
10th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2012, (Özet Bildiri)
77. Antibacterial Activity of 5 Fluorouracil Loaded W O W Nano Emulsions
10th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2012, (Özet Bildiri)
79. Comparison of Gene Delivery into Human Breast Epithelial Cells with PEGylated Cationic Nanoparticles and Liposome Formulations
8th World Meeting on Pharmaceuticals, Biopharmaceuticals and Pharmaceutical Technology, İstanbul, Türkiye, 19 - 22 Mart 2012, ss.20-21, (Tam Metin Bildiri)
81. Development and Formulation of PEGylated Non Viral Gene Delivery Systems
17th International Symposium on Biomedical Science and Technology, Ankara, Türkiye, 23 - 25 Kasım 2011, ss.37, (Tam Metin Bildiri)
82. Studies on the Mucosal Delivery of Microparticulate Antigen Delivery Systems. I-Development and in-vitro Characterization
17th International Symposium on Biomedical Science and Technology, Ankara, Türkiye, 23 - 25 Kasım 2011, ss.62, (Özet Bildiri)
83. Studies on the Stability of 5-FU Loaded Nano-emulsions
17th International Symposium on Biomedical Science and Technology, Ankara, Türkiye, 23 - 25 Kasım 2011, ss.63, (Özet Bildiri)
85. A Model Study Using Bracketing Design for Stability Test on Solid Dosage Form
1st international confrence on New Trends in Chemometrics and Applications, Antalya, Türkiye, 8 - 11 Ekim 2011, ss.62, (Özet Bildiri)
86. Partial least squares and principal component regression for the simultaneous quantitative estimation of diphenhydramine hydrochloride in dry powder and syrup forms in the presence of excipient effects
1st International Conference on New Trends in Chemometrics and Applications, 8 - 11 Ekim 2011
87. Formulation and In-vitro Characterization of 5-Fluorouracil Loaded Multiple Emulsions
18th International Symposium on Microencapsulation, Antalya, Türkiye, 12 - 14 Eylül 2011, ss.234-235, (Tam Metin Bildiri)
88. PEGylated Cationic Nanoparticles Mediated Gene Delivery into Human Breast Epithelial Cells; Preparation, Physicochemical Characterization, and Cellular Uptake
18th International Symposium on Microencapsulation, Antalya, Türkiye, 12 - 14 Eylül 2011, ss.171-173, (Tam Metin Bildiri)
90. Thermoreversible In Situ Gelling Solutions for Ophthalmic Delivery of Pilocarpine Hydrochloride
3rd PharmSciFair, PRAG, Çek Cumhuriyeti, 13 - 17 Haziran 2011
93. pH induced in situ ophthalmic gelling system for ciprofloxacin HP ß CD complex
3rd BBBB International Conference on Pharmaceutical Sciences, Antalya, Türkiye, 26 - 28 Ekim 2009
96. The preparation and characterization of poly lactide co glycolide microspheres containing ovalbumin
9th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 23 - 26 Haziran 2009
97. Thermosensitive prolonged release ophthalmic gel for ciprofloxacin HP ß CD complex
2nd PharmSciFair, Nice, Fransa, 8 - 12 Haziran 2009
99. Preperation and Characterization of PEGylated Chitosan and Polyethylenimine as a Non-viral Gene Delivery
14th International Pharmaceutical Technology Symposium, IPTS, Antalya, Türkiye, 6 - 10 Eylül 2008, ss.17-20, (Tam Metin Bildiri)
100. PEGylated Chitosan Nanoparticles for Gene Delivery
8th International Confrence of the European Chitin Society (EUCHIS’xx07), 8 - 11 Eylül 2007, ss.54, (Tam Metin Bildiri)
102. PEGylated Chitosan-plasmid DNA Nanoparticles: 1)Effect of PEGylation on Drug Loading and Drug Release
3rd World Congress of Board of Pharmaceutical Sciences of FIP, Amsterdam, Hollanda, 22 - 25 Nisan 2007, ss.34, (Özet Bildiri)
103. Comparison study of Chitosan-PEG nanoparticles and PEG coated chitosan nanoparticles for gene delivery
Optimised Biotech Medicines: Second-Generation Pharmaceutical Proteins, EUFEPS, Munich, Almanya, 11 - 12 Ocak 2007, ss.30, (Özet Bildiri)
104. Ciprofloxacin loaded ocular nanoparticles: Preparation and in-vitro charavterization
PharmSciFair, Pharmaceutical Sciences Fair & Exhibition, EUFEPS, Nice, Fransa, 12 - 17 Haziran 2005, ss.214, (Özet Bildiri)
105. Comparison of the Chitosan-DNA Nanoparticles Gene Transfection and Transformation Efficiencies
12th International Pharmaceutical Technology Symposium, IPTS, İstanbul, Türkiye, 12 - 15 Eylül 2004, ss.69-70, (Tam Metin Bildiri)
106. Multiple emulsions (W/O/W) and biodegredable nanoparticles containing influenza virus antigen: Immune response in rats
Optimising Drug Delivery and Formulation: New Challenges in Drug Delivery; EUFEPS, Versailles, Fransa, 29 Eylül - 01 Ekim 2003, ss.159, (Özet Bildiri)
107. Effects on Different Formulations of Chitosan-DNA Nanoparticles on Gene Transfection
30th Annual Meeting and Exposition of the Controlled Release Society, Glasgow, İngiltere, 19 - 23 Temmuz 2003, ss.578-579, (Tam Metin Bildiri)
108. Chitosan-Plasmid DNA Nanoparticles: Effects of Different Molecular Weight Chitosan Nanoparticles on Drug Loading and Drug Release
9th International Symposium on Biomedical Science and Technology, BIOMED, Antalya, Türkiye, 19 - 22 Eylül 2002, sa.29, ss.64, (Özet Bildiri)
109. Chitosan Plasmid DNA Nanoparticles I Characterization and Properties of Different Molecular Weight Chitosan Nanoparticles
3rd World Congress of Pharmaceutical Sciences of FIP, 16 - 18 Eylül 2002, ss.20, (Tam Metin Bildiri)
110. Comparing two Different Methods at Plasmid Purification
7th International Symposium on Pharmaceutical Sciences, ISOPS, Ankara, Türkiye, 24 - 27 Haziran 2002, ss.245, (Özet Bildiri)
111. Poly(lactide-co-glycolide) nanoparticles containing 5-Fluorouracil. II:Formulation Design
4th World Meeting on Pharmaceutics, Biopharmaceutics,Pharmaceutical Technology, Florence, İtalya, 8 - 11 Nisan 2002, ss.809-810, (Tam Metin Bildiri)
112. The experimental Design and Characterisation of PLGA Nanoparticles
FIP, World Congress of Pharmacy and Pharmaceutical Science, Singapore, Singapur, 1 - 06 Eylül 2001, ss.82, (Özet Bildiri)
113. Comperative Study on the Stability and Release of a Model Protein Encapsulated within Biodegredable PLLA and Chitosan Microparticles
The Second International Postgraduate Research Symposium on Pharmaceutics , İstanbul, Türkiye, 6 - 08 Eylül 2000, cilt.17, ss.47, (Özet Bildiri)
114. Factors affecting the stability and release of a model protein encapsulated within biodegredable PLLA microparticles
6th International Symposium on Pharmaceutical Sciences, ISOPS-6, 2000, Ankara Üniversitesi, Ankara, 27 Haziran 2000, (Özet Bildiri)
Kitaplar
26
1. Nadir Hastalıklarda Kullanılan İlaçlarda (Yetim İlaçlar) Güncel Uygulamalar
Turkiye Klinikleri, Ankara, 2024
2. Farmasötik Teknoloji Deneysel Uygulamalar Kitabı
Ankara Üniversitesi, Ankara, 2024
5. Cumhuriyetin 100. Yılında Eczacılıkta Yenilikler 4
Ankara Üniversitesi, Ankara, 2023
6. Biyomimetik Şaperonlar ve Nanobiyoteknolojik Uygulamalarının Değerlendirilmesi
Cumhuriyetin 100. Yılında Eczacılıkta Yenilikler, Asuman Bozkır,İlkay Yıldız, Editör, Ankara Üniversitesi, Ankara, ss.367-380, 2023
7. TÜRK FARMAKOPESİ 2023, 2.7.28.ADSORBE TETANOS AŞISI MİKTAR TAYİNİ; 1219. HEMOFİLUS TİP b KONJUGE AŞISI; 2.7.27.DİFTERİ VE TETANOS TOKSİNLERİ VE TOKSOİTLERİNİN FLOKÜLASYON DEĞERİ (Lf) (RAMON TAYİNİ);2726e. TNF-ALFA ANTAGONİSTLERİNİN POTENSLERİNİN BELİRLENMESİ İÇİN HÜCRE TABANLI TAYİNLER; 2622.HEMOFİLUS TİP b ve MENİNGOKOK GRUP C KONJUGE AŞISI
TÜRK FARMAKOPESİ 2023, TC SAĞLIK BAKANLIĞI, Editör, TC SAĞLIK BAKANLIĞI,TİTCK, Ankara, ss.1-3600, 2023
9. Aşı Üretiminde Kalite Süreci
Aşı Çalışmaları ve Teknolojisi, Mert DÖŞKAYA,Adnan Yüksel GÜRÜZ,Ayşe Gülten KANTARCI,Cemal ÜN, Editör, Nobel Yayınevi, Ankara, ss.471-482, 2023
12. Aşı üretim süreçlerinde kalite denetimi
SD, Recep Öztürk, Editör, Medipol Yayınevi, İstanbul, ss.52-55, 2022
13. Biyobenzer Ürünler, Genel Bakış ve Kılavuzlar Doğrultusunda Değerlendirmeler
Eczacılıkta Yenilikler 3, Gülbin Özçelikay,İlkay Yıldız, Editör, Ankara Üniversitesi, Ankara, ss.359-370, 2020
14. Aşı Lojistiği ve Soğuk Zincir
AŞI Akademik, Endüstriyel ve Resmi Otorite Yönüyle, Sevda Şenel,M. Kürşat Derici, Editör, Hipokrat yayınevi, Ankara, ss.141-146, 2019
15. A new approach for drug targeting to the central nervous system: Lipid nanoparticles
Nanoarchitectonics in Biomedicine, Alexandru Mihai Grumezescu, Editör, Elsevier Science, Oxford/Amsterdam , Bucuresti, ss.335-369, 2019
16. Aşı Uygulama Yolları
Aşı:Akademik, Endüstriyel ve Resmi Otorite Yönüyle, Sevda Şenel,Mehmet Kürşat Derici, Editör, Hipokrat Yayınevi, Ankara, ss.53-59, 2019
17. Biyolojik ve Biyoteknolojik Ürünler Çalışma Grubu (Aşılar-Hemofilus tip b konjuge aşısı)
Türk Farmakopesi 2017, Türkiye İlaç ve Tıbbi Cihaz Kurumu Yayın Komisyonu (Dr. Ali Alkan,Eray Kaplan,Oğuzhan Koyuncu,Selin Ergün Ayan), Editör, Türkiye İlaç ve Tıbbi Cihaz Kurumu Artı 6 Matbaa Ltd. Sti, Ankara, ss.1127-1129, 2018
18. Biyolojik ve Biyoteknolojik Ürünler Çalışma Grubu (Analiz Yöntemleri-Konak Hücre Protein Tayini İşlemleri)
Türk Farmakopesi 2017, Türkiye İlaç ve Tıbbi Cihaz Kurumu Yayın Komisyonu (Dr. Ali Alkan,Eray Kaplan,Oğuzhan Koyuncu,Selin Ergün Ayan, Editör, T.C. Sağlık Bakanlığı, Türkiye İlaç ve Tıbbi Cihaz Kurumu, Artı 6 Matbaa Ltd. Sti., Ankara, ss.267-272, 2018
19. Türk Farmakopesi 2017, Aşılar
Türk Farmakopesi 2017, Sağlık Bakanlığı, Editör, TC SAĞLIK BAKANLIĞI TTİCK, Ankara, ss.1-252, 2018
20. Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery
Multi-Volume SET-Nanostructures in Therapeutic Medicine, Alexandru Mihai Grumezescu, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.169-202, 2017
21. Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery
Multi-Volume SET -Nanostructures in Therapeutic Medicine, Alexandru Mihai Grumezescu, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.169-202, 2017
22. Farmasötik teknoloji deneysel uygulamalar kitabı
Ankara Üniversitesi, Ankara, 2013
23. Biyomakromoleküllerin Formülasyon Tasarımı ve Uygulamalarında, Güncel ve Geleceğe Yönelik Yaklaşımlar
Eczacılıkta Yenilikler 2, Onur Feyyaz, Editör, Ankara Üniversitesi, Ankara, ss.117-142, 2010
25. Farmasötik Teknoloji Deneysel Uygulamalar Kitabı
Ankara Üniversitesi, Ankara, 2007
26. Pegylated Chitosan Nanoparticles for gene delivery
Advances in Chitin Science Volume X, Senel S.,Varum K,Sumnu MM,Hincal AA, Editör, European Chitin Society, Ankara, ss.281-286, 2007
Bilirkişi Raporları
4
Metrikler